Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideIDXXIdexx Laboratories
FinDog View：Neutral
UNHUnitedHealth Group
FinDog View：Neutral
| Metric | IDXX | UNH |
|---|
| Close | 513.62 | 375.26 |
| Market Cap | $40.5B | $337B |
| 1M | −5.95% | −5.15% |
| P/E (TTM) | 35.5 | 23.9 |
| Forward P/E | 35.6 | 19.7 |
| P/E 5-Yr Percentile | 0 | 53 |
| P/S | 8.9 | 0.8 |
| P/B | 25.1 | 3.2 |
| Dividend Yield | — | 1.37% |
| Latest Quarter Revenue | $1.2B | $112B |
| Revenue YoY | +9.7% | +0.4% |
| Gross Margin | 64.0% | 88.1% |
| Latest Quarter EPS | 4.27 | 6.04 |
| Avg Post-Earnings Move | ±1.8% | ±3.1% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.91% | 2.89% |
| 90-Day Net Insider Buying | −$1.2M | −$0.66M |
IDXX · Revenue, Last 8 Quarters ($B)
UNH · Revenue, Last 8 Quarters ($B)
